Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 3/20 | 0.37 |
| ▸ | GRM8 | O00222 | 1/20 | 0.37 |
| ▸ | GRM6 | O15303 | 1/20 | 0.37 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PPP5C | P53041 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ARG1 | P05089 | 3/20 | 0.34 |
| ▸ | ARG2 | P78540 | 2/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3006667 | 0.74 | ARG1 (0.38) | MEN1KMT2APPP5CLMNAARG1 | |
| SCHEMBL8970284 | 0.72 | MEN1 (0.38) | MEN1KMT2APPP5CLMNAHTT | |
| SCHEMBL16391357 | 0.72 | LMNA (0.34) | GRM2GRM3MEN1KMT2APPP5C | |
| SCHEMBL9537184 | 0.71 | MEN1 (0.40) | MEN1KMT2AARG1ARG2ALDH1A1 | |
| SCHEMBL12329169 | 0.71 | ARG1 (0.43) | GRM2GRM8GRM6GRM3MEN1 | |
| SCHEMBL10040088 | 0.70 | GRM4 (0.41) | GRM2GRM8GRM6GRM3MEN1 | |
| SCHEMBL9914758 | 0.70 | GRM4 (0.41) | GRM2GRM8GRM6GRM3MEN1 | |
| SCHEMBL13053337 | 0.69 | GRM2 (0.45) | GRM2GRM3ALDH1A1DPP4 | |
| SCHEMBL7483092 | 0.68 | ALDH1A1 (0.40) | GRM2GRM6GRM3LMNAGRM5 | |
| SCHEMBL12590723 | 0.67 | SMN1; SMN2 (0.33) | LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8834841-B2 | Imaging agents | EMORY UNIVERSITY (US) | 2014-09-16 | — | — | US | disclosed |
| US-20130225828-A1 | IMAGING AGENTS | EMORY UNIVERSITY (US) | 2013-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225828-A1 | IMAGING AGENTS | SLC7A1, SSTR1, SSTR3 | GRM2 692/4885GRM8 1082/4885GRM6 702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.